The Globe and Mail reports in its Friday edition that on Thursday, short seller Nate Anderson of Hindenburg Research took aim at Aphria once again. The Globe's Christina Pellegrini and David Milstead write Mr. Anderson published another report about the company and its ties to a Florida cannabis player Liberty Health Sciences.
Aphria chief executive officer Vic Neufeld is also Liberty's chairman. In April, 2017, Aphria said it was pumping $25-million into Liberty to expand its business into the United States. Clarus Securities Inc. helped Liberty raise another $35-million. According to a regulatory form filed with the Canadian Securities Exchange, the money came from dozens of investors, including key Aphria personnel and what appears to be members of their families.
The regulatory filing suggests Mr. Neufeld owned shares of Liberty before the financings. Mr. Anderson raised the possibility that Mr. Neufeld invested ahead of Aphria and at a much lower price.
A filing in 2017 says Mr. Neufeld bought 280,451 receipts convertible into shares, bringing his ownership to 2.4 million shares.
Mr. Neufeld said the regulatory form was completed incorrectly and that an accurate version would be refiled on Thursday.
© 2019 Canjex Publishing Ltd. All rights reserved.